BridgeMD
New treatment option for Chronic Fatigue Syndrome (CFS)
Official title Photobiomodulation in Chronic Fatigue Syndrome
ClinicalTrials.gov ID: NCT07546539
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether photobiomodulation therapy (low-level laser therapy) can reduce fatigue and improve quality of life in patients with chronic fatigue syndrome (CFS). The study will include adults aged 18-60 years diagnosed with chronic fatigue syndrome.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Age 18-60 years
- Diagnosis of a CFS according to the 2015 Institute of Medicine criteria
- Fatigue Severity Scale (FSS) score ≥ 4
- Ability to understand study procedures and provide informed consent
You likely can't join if
- Comorbid psychiatric conditions (e.g., major depression, schizophrenia)
- Current use of corticosteroids or immunomodulators
- Known photosensitivity or dermatologic contraindications to LLLT
- Participation in structured exercise programs more than twice weekly
- Diagnosed malignancy or active infection -Not willing to be the part of study -
The study team makes the final eligibility decision.
Where it's taking place
- Larkana, Sindh, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Larkana, Sindh, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.